CN1096686A - A kind of production method of high nutrient phosphatide oral liquid - Google Patents
A kind of production method of high nutrient phosphatide oral liquid Download PDFInfo
- Publication number
- CN1096686A CN1096686A CN 93107365 CN93107365A CN1096686A CN 1096686 A CN1096686 A CN 1096686A CN 93107365 CN93107365 CN 93107365 CN 93107365 A CN93107365 A CN 93107365A CN 1096686 A CN1096686 A CN 1096686A
- Authority
- CN
- China
- Prior art keywords
- production method
- oral administration
- essence
- phospholipid
- zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A kind of efficient phospholipid nutrient oral liquor.It is to be major ingredient with the soybean phospholipid, adds V
EMix with unsaturated fatty acid, adjuvant is that Fructus Crataegi, Semen Cassiae add water boil, leaches slag and stays juice, and adjuvant juice and major ingredient mix, and add essence, promptly get product through dispersion, filtration, homogenizing, packing, sterilization, check again.This product can make the middle-older patient blood fat reducing, reduces blood viscosity, and the prevention of arterial sclerosis reaches the danger of prophylactic treatment cardiovascular disease and releasing cerebral thrombosis.
Description
The present invention relates to a kind of production method with high efficiency nutritious oral liquid of blood fat reducing, cholesterol reducing, vessel softening.
Through countries in the world phospholipid expert years of researches, confirm that soybean phospholipid has important health-care effect to human body.Soybean phospholipid contains cephalin, lecithin and lipositol, to reducing body's cholesterol, removing that blood vessel accumulates thing, blood fat reducing has obvious effect.So generally be widely used in chocolate, cookies, margarine oil's wet goods food as food additive abroad with phospholipid.The clear 61-67461 of Japan, 60-153779 has also introduced with phospholipid, V
EWith unsaturated fatty acid be the capsule-shaped food that raw material is made.China begins phospholipid is studied the fifties, and phospholipid is applied as food emulsifying agent, bulking agent.Domestic " bone marrow powder " and some mineral waters of producing have in recent years also all added a little phospholipid, but for various reasons, China also is nowhere near to research, the development and use of phospholipid.
Purpose of the present invention: fully develop the soybean phospholipid resource of China's abundant, develop new product,, particularly reduce middle-aged and elderly people, the sickness rate of cerebrovascular, cardiovascular disease so that improve China people's body constitution.
Key problem in technology of the present invention:
Process route of the present invention: (seeing accompanying drawing):
Description of drawings: adjuvant, the filtration of (4) adjuvant, the mixing of (5) main ingredient, (6) dispersion, (7) filtration, (8) homogenizing, (9) sterilization, (10) packing, (11) check, (12) finished product are boiled in (1) major ingredient batching, (2) adjuvant batching, (3)
Major ingredient batching: soybean lecithin: VE: unrighted acid=1: 0.00005～0.1: 0.05～2.
Auxiliary material batching: water: cassia seed: hawthorn=1: 0.0075～0.04: 0.075～0.06.
Boil auxiliary material: cassia seed, hawthorn, added water boil 30～120 minutes, and filter cleaner stays juice.
Major ingredient mixes and adds 0.001～0.007 essence with 7-20 adjuvant juice doubly, vitamin C 0.001～0.0002, and zinc 0.0002～0.00002, selenium 0.1～5ppm, zinc can be zinc gluconate, zinc lactate, zinc sulfate.Selenium can be Monohydrated selenium dioxide and sodium selenite, stirs.
Disperse: 200～2000n/min stirs, and makes it to disperse.
Filter: 130～350 orders filter.
Homogenizing: 0～400kg/cm
2Homogenizing, 2～10 minutes.
Sterilization: high-temperature short-time sterilization, 121 ℃ of high pressure, sterilization in 15～30 minutes, 60～100 ℃ of normal pressures, sterilization in 20～60 minutes all can.
Check: carry out sense organ, physics and chemistry and microbiological indicator check.Qualified back labeling is product.
Advantage of the present invention:
1, prevention, treatment cardiovascular and cerebrovascular disease.
Contained emulsifying microcapsule among the present invention based on phospholipid, this emulsifying microcapsule is to produce in strict proportioning and strict process, it can make, and cholesterol keeps suspended state in the blood, cholesterol reducing content effectively, blood viscosity lowering, remove the blood vessel wall deposit, alleviate the atherosclerosis degree.Therefore the effect that prevents and slow down the heart and brain cardiovascular disease is arranged, and help the formation of prevention of brain thrombosis.
2, the effect of blood fat reducing, treatment fatty liver.
Contained unsaturated fatty acid in the phosphatide nutrition liquid can strengthen the lipid metabolism function of human body, thereby reach blood fat reducing, lipotropic effect.
3, brain-strengthening, memory reinforcing.
Phospholipid is after enteral is absorbed, and the choline that disengages enters and generates second choline (having another name called " memory is plain ") behind the brain, reaches brain-strengthening, the effect of memory reinforcing.
The present invention once made 30 routine efficacy experiments in 1992, after made 33 routine efficacy experiments in cadre's sanitarium, temple, Headquarters of the General Staff arctic hospital again.Male's 28 examples wherein, women's 5 examples, the age is between 32 years old～78 years old.The patient is hospital diagnosis and is " hyperlipidemia " disease patient, medical history 1～20 year.High person's 16 examples of blood fat wherein, and with fatty liver person 5 examples, hemiplegia one example, seborrheic dermatitis of head one example.Instructions of taking: (medicine) being taken before meal was taken about the 20 minutes No drinkings 50 in front and back and was spent above hot water, hot tea with 10 milliliters of phosphatide oral liquids sooner or later every day.Take effect: 1, the high patient of cholesterol, the overwhelming majority has decline in various degree, and fall does not wait at 11～180 milligrams.When 2, finding in the observation that cholesterol descends, triglyceride rises relatively, but will excrete rapidly.High density lipoprotein is on the rise.3, cholesterol is high more, and medical history is long more, and it is remarkable more to descend.4, after the paralytic took, muscular strength and spirit, language before took a favorable turn.5, after patients with seborrheic dermatitis was taken, the dandruff obviously reduced.6, take by explanation and have no adverse reaction and toxic and side effects.
Embodiment 1:15kg soybean phospholipid adds 10 gram V
E, the 10kg wheat germ oil mixes.Other gets the 2.5kg Semen Cassiae, adds the 300kg decocting in water 40 minutes, filters out juice, adds bright protein sugar 0.65kg, chocolate essence 1.52kg zinc lactate 25g again, and sodium selenite 0.9g vitamin C 160g and soybean phospholipid mixture mix.People's colloid mill 400n/min stirs, and makes it to disperse 30 minutes, and 300 mesh sieves filter, and normal pressure 5000n/min homogenizing is 3 minutes again, and through 121 ℃, 3200 bottles of products are packed out in sterilization in 30 minutes.
Embodiment 2:0.5kg glues shape phospholipid, adds natural V
E7.2g and 0.2kg fish oil mixes.Other gets Fructus Crataegi 0.2kg and adds water 5kg and boiled 30 minutes, leaches juice, and with sucrose 0.5kg, lychee flavor 30g, sodium selenite 8mg, vitamin C 4g, zinc gluconate 1.3g, mix with the soybean phospholipid mixture cooling back, injects colloid mill 800n/min and stirred 30 minutes, make it to disperse, 250 eye mesh screens filter, normal pressure 8000n/min homogenizing, 70 ℃, sterilization in open kettle 60 minutes goes out 60 bottles of products.Through health anti-station check, total number of bacteria＜1/g, coliform＜3/100ml.
Claims (7)
1, a kind of production method of nutrition oral administration is characterized in that: this nutritional solution is major ingredient with the soybean phospholipid, soybean phospholipid, V
E, unsaturated fatty acid mixes, its proportioning is 1: 0.00005～0.1: 0.05～2, adjuvant, water, Semen Cassiae, Fructus Crataegi, its proportioning is 1: 0.0075～0.04: 0.075～0.06, Fructus Crataegi, Semen Cassiae add the water temperature fire and boiled 30～120 minutes, and the filtering slag stays juice, 7～20 times juice and soybean phospholipid, V
E, the unsaturated fatty acids acid blend mixes, and adds 0.001～0.007 essence and sweeting agent vitamin C 0.001～0.0002 simultaneously, zinc 0.0002～0.00002, selenium 0.1～5ppm, colloid mill is injected in the back, and 200～2000n/min stirs, make it to disperse, filter 0～400kg/cm thereafter
2Finished product is sterilized, packs, checked out to homogenizing 2～10 minutes.
2, the production method of nutrition oral administration according to claim 1 is characterized in that soybean phospholipid can be concentrated phosphatide, separating phospholipids, powder phospholipid.
3, the production method of nutrition oral administration according to claim 1 is characterized in that unsaturated fatty acid can be linoleic acid, linolenic acid, arachidonic acid, eicosapentaenoic acid.
4, the production method of nutrition oral administration according to claim 1 is characterized in that vitamin E can be synthetic alpha-tocopherol, also can be the natural V that extracts from vegetable oil
E
5,, it is characterized in that said essence can be chocolate essence, egg milk essence, lychee flavor, flavoring orange essence, flavoring pineapple essence according to the production method of the said nutrition oral administration of claim 1.
6, the production method of a kind of nutrition oral administration according to claim 1 is characterized in that sterilization, can be high-temperature short-time sterilization, 121 ℃ of sterilizations in 15～30 minutes of high pressure, 60～100 ℃ of normal pressures, sterilization in 20-60 minute.
7, the production method of a kind of nutrition oral administration according to claim 1 is characterized in that zinc can be that zinc gluconate, zinc lactate, zinc sulfate, selenium can be Monohydrated selenium dioxide and sodium selenite.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93107365 CN1039783C (en) | 1993-06-24 | 1993-06-24 | Producing method of high nutrient phosphatide oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93107365 CN1039783C (en) | 1993-06-24 | 1993-06-24 | Producing method of high nutrient phosphatide oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1096686A true CN1096686A (en) | 1994-12-28 |
| CN1039783C CN1039783C (en) | 1998-09-16 |
Family
ID=4986651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93107365 Expired - Fee Related CN1039783C (en) | 1993-06-24 | 1993-06-24 | Producing method of high nutrient phosphatide oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1039783C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109198042A (en) * | 2018-10-22 | 2019-01-15 | 辽渔南极磷虾科技发展有限公司 | A kind of high EPA/DHA type antarctic krill oil phosphatide oral liquid and preparation method thereof |
| CN109439430A (en) * | 2018-10-22 | 2019-03-08 | 辽渔南极磷虾科技发展有限公司 | A kind of method of refining of antarctic krill oil |
-
1993
- 1993-06-24 CN CN 93107365 patent/CN1039783C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109198042A (en) * | 2018-10-22 | 2019-01-15 | 辽渔南极磷虾科技发展有限公司 | A kind of high EPA/DHA type antarctic krill oil phosphatide oral liquid and preparation method thereof |
| CN109439430A (en) * | 2018-10-22 | 2019-03-08 | 辽渔南极磷虾科技发展有限公司 | A kind of method of refining of antarctic krill oil |
| CN109439430B (en) * | 2018-10-22 | 2021-10-08 | 辽渔南极磷虾科技发展有限公司 | Euphausia superba oil refining method |
| CN109198042B (en) * | 2018-10-22 | 2021-10-08 | 辽渔南极磷虾科技发展有限公司 | high-EPA/DHA type antarctic krill oil phospholipid oral liquid and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1039783C (en) | 1998-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103039605A (en) | Pregnant woman milk powder capable of restraining early pregnancy reaction and preparation method thereof | |
| CN108835262A (en) | A kind of modulation milk powder and preparation method thereof improving memory | |
| CN102429307A (en) | Low-calorie and total-nutrient beverage and preparation method thereof | |
| CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
| CN110214940A (en) | A kind of full nutrition special medicine purposes formula nutritional liquid of adult and preparation method thereof | |
| CN101415429B (en) | Fat accumulation inhibitor | |
| CN107660620A (en) | A kind of sheep base oil grease microcapsule powder and preparation method thereof | |
| CN104855516A (en) | Preparation method for vinegar-egg milk beverage suitable for conditioning of patients suffering from cardiovascular and cerebrovascular diseases | |
| CN107535605A (en) | A kind of middle-and-old-aged milk and preparation method thereof | |
| CN1108891A (en) | Enhanced milk containing polyunsaturated fatty acid | |
| CN1039783C (en) | Producing method of high nutrient phosphatide oral liquid | |
| CN105054164A (en) | Health-care pumpkin seed beverage and processing method thereof | |
| CN109169961A (en) | A kind of edible blend oil and preparation method thereof for preventing and treating prediabetes | |
| CN1298647A (en) | Health-care oil for regulating blood fat | |
| CN1739401A (en) | Alcohol effect dispelling health beverage and its prepn process | |
| CN106261343A (en) | A kind of composite health care beverage with antihypertensive function and preparation method thereof | |
| CN1080180A (en) | Oral liquid for increasing milk | |
| CN1323593C (en) | Method for preparing milk contg. micron ginseng, antler, pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium | |
| CN1557469A (en) | Natural calcium replenishing nutrient | |
| CN1784992A (en) | Method for producing sour soymilk contg. microo Yinlanzha konjak sugar for reducing-weight and lowering blood-fat | |
| CN101816422A (en) | Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof | |
| DE3590083T (en) | Sour milk product | |
| CN1117823A (en) | Kelp extract and preparation method thereof | |
| CN100364423C (en) | Preparation method of fat-reducing blood sugar-reducing milk containing micro gingko leaf, Gymostamma pentaphyllum, haw and konnjaku powder | |
| CN1370564A (en) | Composite perilla oil prepn and its production process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |